Log in to save to my catalogue

Clinical efficacy assessment in severe vernal keratoconjunctivitis: preliminary validation of a new...

Clinical efficacy assessment in severe vernal keratoconjunctivitis: preliminary validation of a new...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_32341771

Clinical efficacy assessment in severe vernal keratoconjunctivitis: preliminary validation of a new penalties-adjusted corneal fluorescein staining score

About this item

Full title

Clinical efficacy assessment in severe vernal keratoconjunctivitis: preliminary validation of a new penalties-adjusted corneal fluorescein staining score

Publisher

United States: Routledge

Journal title

Journal of market access & health policy, 2020, Vol.8 (1), p.1748492

Language

English

Formats

Publication information

Publisher

United States: Routledge

More information

Scope and Contents

Contents

Introduction and objective: Vernal keratoconjunctivitis (VKC) is a rare allergic eye condition that occurs in children and is characterised by a combination of debilitating symptoms. Repeated use of topical corticosteroid rescue therapy is often necessary in severe forms. This study aims to assess the validity of a new composite endpoint: the penal...

Alternative Titles

Full title

Clinical efficacy assessment in severe vernal keratoconjunctivitis: preliminary validation of a new penalties-adjusted corneal fluorescein staining score

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_32341771

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_32341771

Other Identifiers

ISSN

2001-6689

E-ISSN

2001-6689

DOI

10.1080/20016689.2020.1748492

How to access this item